VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment

Uterine receptivity and embryo implantation are two main processes that need a finely regulated balance between pro-inflammatory and tolerogenic mediators to allow a successful pregnancy. The neuroimmune peptide vasoactive intestinal peptide (VIP) is a key regulator, and it is involved in the induct...

Full description

Bibliographic Details
Main Authors: Lucila Gallino, Vanesa Hauk, Laura Fernández, Elizabeth Soczewski, Soledad Gori, Esteban Grasso, Guillermina Calo, Nora Saraco, Esperanza Berensztein, James A. Waschek, Claudia Pérez Leirós, Rosanna Ramhorst
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02907/full
_version_ 1819161929710567424
author Lucila Gallino
Vanesa Hauk
Laura Fernández
Elizabeth Soczewski
Soledad Gori
Esteban Grasso
Guillermina Calo
Nora Saraco
Esperanza Berensztein
James A. Waschek
Claudia Pérez Leirós
Rosanna Ramhorst
author_facet Lucila Gallino
Vanesa Hauk
Laura Fernández
Elizabeth Soczewski
Soledad Gori
Esteban Grasso
Guillermina Calo
Nora Saraco
Esperanza Berensztein
James A. Waschek
Claudia Pérez Leirós
Rosanna Ramhorst
author_sort Lucila Gallino
collection DOAJ
description Uterine receptivity and embryo implantation are two main processes that need a finely regulated balance between pro-inflammatory and tolerogenic mediators to allow a successful pregnancy. The neuroimmune peptide vasoactive intestinal peptide (VIP) is a key regulator, and it is involved in the induction of regulatory T cells (Tregs), which are crucial in both processes. Here, we analyzed the ability of endogenous and exogenous VIP to sustain a tolerogenic microenvironment during the peri-implantation period, particularly focusing on Treg recruitment. Wild-type (WT) and VIP-deficient mice [heterozygous (HT, +/−), knockout (KO, −/−)], and FOXP3-knock-in-GFP mice either pregnant or in estrus were used. During the day of estrus, we found significant histological differences between the uterus of WT mice vs. VIP-deficient mice, with the latter exhibiting undetectable levels of FOXP3 expression, decreased expression of interleukin (IL)-10, and vascular endothelial growth factor (VEGF)c, and increased gene expression of the Th17 proinflammatory transcription factor RORγt. To study the implantation window, we mated WT and VIP (+/−) females with WT males and observed altered FOXP3, VEGFc, IL-10, and transforming growth factor (TGF)β gene expression at the implantation sites at day 5.5 (d5.5), demonstrating a more inflammatory environment in VIP (+/−) vs. VIP (+/+) females. A similar molecular profile was observed at implantation sites of WT × WT mice treated with VIP antagonist at d3.5. We then examined the ability GFP-sorted CD4+ cells from FOXP3-GFP females to migrate toward conditioned media (CM) obtained from d5.5 implantation sites cultured in the absence/presence of VIP or VIP antagonist. VIP treatment increased CD4+FOXP3+ and decreased CD4+ total cell migration towards implantation sites, and VIP antagonist prevented these effects. Finally, we performed adoptive cell transfer of Tregs (sorted from FOXP3-GFP females) in VIP-deficient-mice, and we observed that FOXP3-GFP cells were mainly recruited into the uterus/implantation sites compared to all other tested tissues. In addition, after Treg transfer, we found an increase in IL-10 expression and VEGFc in HT females and allowed embryo implantation in KO females. In conclusion, VIP contributes to a local tolerogenic response necessary for successful pregnancy, preventing the development of a hostile uterine microenvironment for implantation by the selective recruitment of Tregs during the peri-implantation period.
first_indexed 2024-12-22T17:20:09Z
format Article
id doaj.art-3724df3d88e04688bd3a950ed0823b54
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T17:20:09Z
publishDate 2020-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-3724df3d88e04688bd3a950ed0823b542022-12-21T18:18:50ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-01-011010.3389/fimmu.2019.02907502984VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic MicroenvironmentLucila Gallino0Vanesa Hauk1Laura Fernández2Elizabeth Soczewski3Soledad Gori4Esteban Grasso5Guillermina Calo6Nora Saraco7Esperanza Berensztein8James A. Waschek9Claudia Pérez Leirós10Rosanna Ramhorst11CONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaServicio de Endocrinología, Hospital Pediátrico Dr. Juan P. Garrahan, CONICET, Universidad de Buenos Aires, Buenos Aires, ArgentinaServicio de Endocrinología, Hospital Pediátrico Dr. Juan P. Garrahan, CONICET, Universidad de Buenos Aires, Buenos Aires, ArgentinaDepartment of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, United StatesCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaCONICET, Laboratorio de Inmunofarmacología, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Universidad de Buenos Aires, Buenos Aires, ArgentinaUterine receptivity and embryo implantation are two main processes that need a finely regulated balance between pro-inflammatory and tolerogenic mediators to allow a successful pregnancy. The neuroimmune peptide vasoactive intestinal peptide (VIP) is a key regulator, and it is involved in the induction of regulatory T cells (Tregs), which are crucial in both processes. Here, we analyzed the ability of endogenous and exogenous VIP to sustain a tolerogenic microenvironment during the peri-implantation period, particularly focusing on Treg recruitment. Wild-type (WT) and VIP-deficient mice [heterozygous (HT, +/−), knockout (KO, −/−)], and FOXP3-knock-in-GFP mice either pregnant or in estrus were used. During the day of estrus, we found significant histological differences between the uterus of WT mice vs. VIP-deficient mice, with the latter exhibiting undetectable levels of FOXP3 expression, decreased expression of interleukin (IL)-10, and vascular endothelial growth factor (VEGF)c, and increased gene expression of the Th17 proinflammatory transcription factor RORγt. To study the implantation window, we mated WT and VIP (+/−) females with WT males and observed altered FOXP3, VEGFc, IL-10, and transforming growth factor (TGF)β gene expression at the implantation sites at day 5.5 (d5.5), demonstrating a more inflammatory environment in VIP (+/−) vs. VIP (+/+) females. A similar molecular profile was observed at implantation sites of WT × WT mice treated with VIP antagonist at d3.5. We then examined the ability GFP-sorted CD4+ cells from FOXP3-GFP females to migrate toward conditioned media (CM) obtained from d5.5 implantation sites cultured in the absence/presence of VIP or VIP antagonist. VIP treatment increased CD4+FOXP3+ and decreased CD4+ total cell migration towards implantation sites, and VIP antagonist prevented these effects. Finally, we performed adoptive cell transfer of Tregs (sorted from FOXP3-GFP females) in VIP-deficient-mice, and we observed that FOXP3-GFP cells were mainly recruited into the uterus/implantation sites compared to all other tested tissues. In addition, after Treg transfer, we found an increase in IL-10 expression and VEGFc in HT females and allowed embryo implantation in KO females. In conclusion, VIP contributes to a local tolerogenic response necessary for successful pregnancy, preventing the development of a hostile uterine microenvironment for implantation by the selective recruitment of Tregs during the peri-implantation period.https://www.frontiersin.org/article/10.3389/fimmu.2019.02907/fullearly pregnancytoleranceVIPtregsimplantation
spellingShingle Lucila Gallino
Vanesa Hauk
Laura Fernández
Elizabeth Soczewski
Soledad Gori
Esteban Grasso
Guillermina Calo
Nora Saraco
Esperanza Berensztein
James A. Waschek
Claudia Pérez Leirós
Rosanna Ramhorst
VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment
Frontiers in Immunology
early pregnancy
tolerance
VIP
tregs
implantation
title VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment
title_full VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment
title_fullStr VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment
title_full_unstemmed VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment
title_short VIP Promotes Recruitment of Tregs to the Uterine–Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment
title_sort vip promotes recruitment of tregs to the uterine placental interface during the peri implantation period to sustain a tolerogenic microenvironment
topic early pregnancy
tolerance
VIP
tregs
implantation
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02907/full
work_keys_str_mv AT lucilagallino vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT vanesahauk vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT laurafernandez vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT elizabethsoczewski vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT soledadgori vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT estebangrasso vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT guillerminacalo vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT norasaraco vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT esperanzaberensztein vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT jamesawaschek vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT claudiaperezleiros vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment
AT rosannaramhorst vippromotesrecruitmentoftregstotheuterineplacentalinterfaceduringtheperiimplantationperiodtosustainatolerogenicmicroenvironment